Marinus Pharmaceuticals
MRNS
#10575
Rank
A$45.32 M
Marketcap
A$0.82
Share price
0.00%
Change (1 day)
-63.40%
Change (1 year)

Earnings for Marinus Pharmaceuticals (MRNS)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Marinus Pharmaceuticals's latest financial reports the company's current earnings are A$31.46 Million. In 2023 the company made an earning of -A$0.22 Billion a decrease over its 2022 earnings that were of -A$24.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marinus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion-1.94%
2023 -A$0.22 Billion770.17%
2022 -A$24.52 Million-83.37%
2021 -A$0.15 Billion46.39%
2020 -A$0.11 Billion24.67%
2019 -A$80.78 Million47.37%
2018 -A$54.82 Million94.33%
2017 -A$28.21 Million-34.02%
2016 -A$42.76 Million15.24%
2015 -A$37.1 Million129.47%
2014 -A$16.17 Million105.55%
2013 -A$7.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Supernus Pharmaceuticals
SUPN
-A$54.02 Million-74.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.57 Billion 1,602.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AcelRx Pharmaceuticals
ACRX
-A$15.36 Million-92.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
A$53.22 M-125.38%๐Ÿ‡บ๐Ÿ‡ธ USA